5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Contributions of 12/15-Lipoxygenase to bleeding in the brain following ischemic stroke

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Ischemic strokes are caused by one or more blood clots that typically obstruct one of the major arteries in the brain, but frequently also result in leakage of the blood-brain barrier and subsequent hemorrhage. While it has long been known that the enzyme 12/15-lipoxygenase (12/15-LOX) is up-regulated following ischemic strokes and contributes to neuronal cell death, recent research has shown an additional major role for 12/15-LOX in causing this hemorrhagic transformation. These findings have important implications for the use of 12/15-LOX inhibitors in the treatment of stroke.

          Related collections

          Author and article information

          Journal
          0121103
          280
          Adv Exp Med Biol
          Adv. Exp. Med. Biol.
          Advances in experimental medicine and biology
          0065-2598
          2214-8019
          9 April 2020
          2019
          08 June 2020
          : 1161
          : 125-131
          Affiliations
          [1. ]Neuroprotection Research Laboratory, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
          [2. ]Zhuhai Interventional Medical Center, Zhuhai Precision Medical Center, Zhuhai People’s Hospital of Jinan University, Zhuhai, Guangdong, China
          [3. ]Institute of Neurological Sciences and Psychiatry, Hacettepe University, Ankara, Turkey
          [4. ]Medicana Bursa Hospital, Neurosurgery Clinic, Odunluk Mh. İzmir yolu Cd. No 41, 16110 Nilüfer / BURSA
          [5. ]Department of Chemistry and Biochemistry, University of California at Santa Cruz, Santa Cruz, CA, US
          Author notes
          [# ]Corresponding Author: Klaus van Leyen, Ph. D., Neuroprotection Research Laboratories, Dept. of Radiology, Massachusetts General Hospital, 149 13th St., R. 2401, Charlestown, MA 02129, (617) 724-6556, klaus_vanleyen@ 123456hms.harvard.edu
          Article
          PMC7278041 PMC7278041 7278041 nihpa1582813
          10.1007/978-3-030-21735-8_12
          7278041
          31562627
          14d5434a-8b16-4ff6-a578-bc4e6098ffb0
          History
          Categories
          Article

          ischemic stroke,STAT6,warfarin,neuroprotection,tPA,tissue plasminogen activator,blood-brain barrier,ischemia,hemorrhagic transformation,hemorrhage,15-HETE,12-HETE,eicosanoid,lipoxygenase

          Comments

          Comment on this article